Collectively, these findings indicate a substantial role for the TNF-α pathway in the development of kidney fibrosis and imply that TNF-α inhibition could become an adjunct therapeutic strategy for CKD with fibrosis. This evidence concerns the gene TNF and chronic kidney disease.